Clinical Trials Directory

Trials / Conditions / Male Breast Carcinoma

Male Breast Carcinoma

17 registered clinical trials studyying Male Breast Carcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingAccess to Genetic Testing in Underserved Patients With Cancer
NCT06422455
University of Southern CaliforniaN/A
CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Ca
NCT02206334
NRG OncologyPhase 1
CompletedDinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer
NCT01624441
National Cancer Institute (NCI)Phase 1
CompletedFLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Nega
NCT01928186
University of WashingtonN/A
CompletedAzacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
NCT01349959
National Cancer Institute (NCI)Phase 2
CompletedVeliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metasta
NCT01281150
National Cancer Institute (NCI)Phase 1
CompletedWeekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Remo
NCT01276496
National Cancer Institute (NCI)Phase 1
TerminatedRO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metas
NCT01217411
National Cancer Institute (NCI)Phase 1 / Phase 2
TerminatedRO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cance
NCT01149356
National Cancer Institute (NCI)Phase 1
CompletedVeliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer
NCT01145430
National Cancer Institute (NCI)Phase 1
CompletedGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
NCT01131234
National Cancer Institute (NCI)Phase 1
CompletedPaclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Trea
NCT00861705
National Cancer Institute (NCI)Phase 2
CompletedPaclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Ca
NCT00770809
National Cancer Institute (NCI)Phase 3
CompletedCixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
NCT00699491
National Cancer Institute (NCI)Phase 1 / Phase 2
TerminatedPazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That
NCT00450879
National Cancer Institute (NCI)Phase 1
CompletedLapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Re
NCT00118157
National Cancer Institute (NCI)Phase 2
CompletedNeoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic S
NCT00070252
National Cancer Institute (NCI)Phase 1 / Phase 2